Dr. Paul Hébert

picpaulhebertDr. Hébert is the Chair of the Canadian Critical Care trials Group, full professor of Medicine at the Université de Montréal, Physician in chief at the Centre Hospitalier de Université de Montréal (CHUM) and a senior scientist at CRCHUM.

He is best known for several seminal studies examining the clinical consequences of transfusion practice – a CCCTG program of research. From January 2007 to September 2011, Dr. Hébert was Editor-in-Chief of the Canadian Medical Association Journal (CMAJ). From November 2008 through June 2010, he was strategic lead (and advisor to the president of the CIHR) on the Strategy for Patient-Oriented Research(SPOR), a partnered initiative led by CIHR with a vision to improve health outcomes through research. Principal investigator or co-investigator in more than 50 peer reviewed research projects, he secured and managed over 63 million in research project funding. Finally, he is having more than 375 publications in peer reviewed journals.